NT-proBNP in Stable COPD and Future Exacerbation Risk: Analysis of the SPIROMICS Cohort

BACKGROUND: High N-terminal pro-brain natriuretic peptide (NT-proBNP) during COPD exacerbations is associated with worse clinical outcomes. The prognostic value of NT-proBNP measured during clinical stability has not been well characterized. METHODS: We studied SPIROMICS participants 40–80 years of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Respir Med
Autors principals: Labaki, Wassim W., Xia, Meng, Murray, Susan, Curtis, Jeffrey L., Barr, R. Graham, Bhatt, Surya P., Bleecker, Eugene R., Hansel, Nadia N., Cooper, Christopher B., Dransfield, Mark T., Wells, J. Michael, Hoffman, Eric A., Kanner, Richard E., Paine, Robert, Ortega, Victor E., Peters, Stephen P., Krishnan, Jerry A., Bowler, Russell P., Couper, David J., Woodruff, Prescott G., Martinez, Fernando J., Martinez, Carlos H., Han, MeiLan K.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6084793/
https://ncbi.nlm.nih.gov/pubmed/29957287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmed.2018.06.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars